Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments

Welzel, Tatjana; Zapf, Beate; Klotsche, Jens; Satirer, Oezlem; Benseler, Susanne M.; Kuemmerle-Deschner, Jasmin B.

dc.contributor.author	Welzel, Tatjana
dc.contributor.author	Zapf, Beate
dc.contributor.author	Satirer, Özlem
dc.contributor.author	Kümmerle-Deschner, Jasmin
dc.date.accessioned	2025-02-18T09:20:12Z
dc.date.available	2025-02-18T09:20:12Z
dc.date.issued	2024
dc.identifier.issn	2077-0383
dc.identifier.uri	http://hdl.handle.net/10900/162185
dc.language.iso	en	de_DE
dc.publisher	Basel : Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/jcm13082319	de_DE
dc.subject.ddc	610	de_DE
dc.title	Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_02157
utue.personen.roh	Welzel, Tatjana
utue.personen.roh	Zapf, Beate
utue.personen.roh	Klotsche, Jens
utue.personen.roh	Satirer, Oezlem
utue.personen.roh	Benseler, Susanne M.
utue.personen.roh	Kuemmerle-Deschner, Jasmin B.
dcterms.isPartOf.ZSTitelID	Journal of Clinical Medicine	de_DE
dcterms.isPartOf.ZS-Issue	Article 2319	de_DE
dcterms.isPartOf.ZS-Volume	13 (8)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE